Drugs / HEP-IV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02966080 | Dec 2016 → Dec 2020 | acute respiratory failure, hemorrhagic disease | University of Arizona | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEP-IV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02966080 ↗ |
| Route | Intravenous | “receive intravenous unfractionated heparin” NCT02966080 ↗ |